Society of Nuclear Medicine and Molecular Imaging (SNMMI)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), formerly the Society of Nuclear Medicine, is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging (PET and SPECT). The bulk of nuclear imaging exams relate to oncology, about a third to cardiac imaging and the rest for a variety of protocols, including imaging inflammation and beta-amyloid plaques that cause Alzheimer's disease. 

RSS icon

Imaging advocacy group warns of supply shortage that’s having ‘profound negative impact’ on patient care

Radiologists took to Twitter to voice their frustrations over the worsening situation, while the manufacturer issued an update Thursday.   

FAPI PET/CT shows promise as a better radiotracer for cancer than 18F-FDG. It also can be used for detection of infection and inflammation.

VIDEO: 6 key advances in molecular imaging technology for PET and SPECT

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been dected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

Thumbnail

CMS coverage decision for Alzheimer's drug, related PET scans sparks concern in imaging community

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

brain money alzheimer dementia

Imaging industry advocate slams feds’ failure to address PET coverage gap in recent ruling

The Society for Nuclear Medicine & Molecular Imaging expressed "strong opposition" following CMS' decision, arguing there is no evidence to support limiting pay for such scans. 

Thumbnail

FDA approves new therapy, complementary imaging agent for treating metastatic prostate cancer

Provider advocates praised the decision, calling it “one of the greatest success stories in nuclear medicine history.”

Thumbnail

Several medical imaging societies ask to be involved in Congressional Medicare reform efforts

Numerous medical imaging societies, including the ACR, signed onto a letter dated Feb. 25 that was sent to members of Congress requesting collaboration on reforms to the Medicare physician payment system.

brain money alzheimer dementia

Imaging advocate concerned after CMS grants limited coverage of controversial Alzheimer’s drug, related PET scans

SNMMI believes the proposed payment pathway will prevent patients' access to diagnosis and treatment.

Displaying 1 - 8 of 16

Around the web

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Health Imaging
Outdated manuals pose MRI safety risks for patients with medical implants

After reviewing years of data from its clinic, one institution discovered that issues with implant data integrity frequently put patients at risk. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup